Back to Journals

Neuropsychiatric Disease and Treatment

Call For Papers

Editor-in-Chief: Dr Roger M Pinder

Neuropsychiatric Disease and Treatment is indexed online:

  • PubMed and PubMed Central (Neuropsychiatr Dis Treat) 
  • Science Citation Expanded (also known as SciSearch®)
  • Journal Citation Reports/Science Edition
  • Current Contents®/Clinical Medicine
  • The American Psychological Association's 'PsycINFO' database
  • Embase, from 2006 (Correct as at December 8, 2016)
  • Scopus, from 2006 (Correct as at December 8, 2016)
  • Index Copernicus
  • Directory of Open Access Journals (DOAJ)
  • OAIster: The Open Access Initiative 

Journal Impact Factor: 2.157 (5 year impact 2.637) 

What is the advantage to you of publishing in Neuropsychiatric Disease and Treatment?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although Neuropsychiatric Disease and Treatment receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Neuropsychiatric Disease and Treatment has a quicker turnaround time than this. Generally peer review is complete within 4-7 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 9 weeks for a final decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.

PubMed Central
Neuropsychiatric Disease and Treatment is indexed on PubMed Central (title abreviation: Neuropsychiatr Dis Treat).  All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.

Yours sincerely
Dr Roger M. Pinder
Neuropsychiatric Disease and Treatment

Email: Editor-in-Chief